Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents

Dermatology

Volumn 220, Issue 2, 2010, Pages 164-168

  Baudraz Rosselet, Florence ^a   Ruffieux, Catherine ^b   Lurati, Massimo ^a   Bontems, Olympia ^a   Monod, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

Acremonium; Aspergillus; Fusarium; Onychomycosis; Trichophyton

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE;

ACREMONIUM; ADULT; ARTICLE; ASPERGILLUS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; DNA EXTRACTION; FEMALE; FUNGUS IDENTIFICATION; FUSARIUM; HUMAN; MALE; ONYCHOMYCOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ACREMONIUM; ADULT; ANTIFUNGAL AGENTS; ASPERGILLUS; FEMALE; FLUCONAZOLE; FOOT DERMATOSES; FUSARIUM; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; MORPHOLINES; NAPHTHALENES; ONYCHOMYCOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 77949264303     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000277762     Document Type: Article

References (25)

1. Chabasse D: Epidémiologie et átiologie des onychomycoses; in Baran R, Piárard GE (eds): Onychomycoses. Paris, Masson, 2004, pp 1-35.
2. Piárard-Franchimont C, Kharfi M, Piárard GE: Prálèvements et examens mycologiques des onychomycoses; in Baran R, Piárard GE (eds): Onychomycoses. Paris, Masson, 2004, pp 79-90.
3. Summerbell RC, Kane J, Kradjen S: Onychomycosis, tinea pedis and tinea manuum caused by nondermatophytic fungi. Mycoses 1989;32:609-619.
4. Summerbell RC, Cooper E, Bunn U, Jamieson F, Gubta AK: Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes. Med Mycol 2005;43:39-59.
5. Monod M, Bontems O, Zaugg C, Láchenne B, Fratti M, Panizzon R: Fast and reliable PCR/sequencing/RFLP assay for identification of fungi in onychomycoses. J Med Microbiol 2006;55:1211-1216.
6. Bontems O, Hauser PM, Monod M: Evaluation of a PCR-RFLP assay for dermatophyte and non-dermatophyte identification in onychomycosis. Br J Dermatol 2009;161:791-796.
7. Monod M, Baudraz-Rosselet F, Ramelet AA, Frenk E: Direct mycological examination in dermatology: a comparison of different methods. Dermatologica 1989;179:183-186.
8. De Hoog GS, Guarro J, Gená J, Figueras MJ: Atlas of Clinical Fungi, ed 2. Utrecht, Centraalbureau voor schimmelcultures, 2000.
9. English MP: Nails and fungi. Br J Dermatol 1976;94:697-701.
10. Dordain-Bigot ML, Baran R, Baixench MT, Bazex J: Fusarium onychomycosis. Ann Dermatol Venereol 1996;123:191-193.
11. Tosti A, Piraccini BM, Lorenzi S: Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000;42:217-224.
12. Gupta AK, Gregurek-Novak T, Konnikov N, Lynde CW, Hofstader S, Summerbell RC: Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. J Cutan Med Surg 2001;5:206-210.
13. Tosti A, Piraccini BM, Lorenzi S, Iorizzo M: Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol Clin 2003;21:491-497.
14. Brasch J, Köppl G: Persisting onychomycosis caused by Fusarium solani in an immunocompetent patient. Mycoses 2009;52:285-286.
15. Epstein E: How often does oral treatment of toenail onychomycosis produce a diseasefree nail? An analysis of published data. Arch Dermatol 1998;134:1551-1554.
16. Baran R: Schámas thárapeutiques; in Baran R, Piárard GE (eds): Onychomycoses. Paris, Masson, 2004, pp 133-165.
17. Arrese JE, Piárard GE: Treatment failures and relapses in onychomycosis: a stubborn clinical problem (review). Dermatology 2003;207:255-260.
18. Trovato L, Rapisarda MF, Greco AM, Galata F, Oliveri S: In vitro susceptibility of nondermatophyte molds isolated from onycomycosis to antifungal drugs. J Chemother 2009;21:403-407.
19. Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC: In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol DOI: 10.1111/j.1365-2230. 2009.03698.x.
20. Goettmann S, Baran R: Onychopathies; in Dubertret L, Aractingi S, Bodemer C, Cribier B, Bachelez H, Chosidow O, Joly P (eds): Thárapeutique dermatologique. Paris, Flamarion, 2001, pp 591-599.
21. Selleslag D: A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B. Acta Biomed 2006; 77(suppl 2):32-35.
22. Guilhermetti E, Takahachi G, Shinobu CS, Svidzinski TI: Fusarium spp. as agents of onychomycosis in immunocompetent hosts. Int J Dermatol 2007;46:822-826.
23. Scherer WP, McCreary JP, Hayes WW: The diagnosis of onychomycosis in a geriatric population: a study of 450 cases in South Florida. J Am Podiatr Med Assoc 2001;91:456-464.
24. Sobera JO, Elewski BE: Fungal diseases; in Bolognia JL, Jorizzo JL, Rapini RP (eds): Dermatology, ed 2. London, Mosby, 2008, pp 1135-1163.
25. Baran R, Tosti A, Piraccini BM: Uncommon clinical patterns of Fusarium nail infection: report of three cases. Br J Dermatol 1997;136:424-427.